Literature DB >> 2405172

Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa.

R Gope1, M A Christensen, A Thorson, H T Lynch, T Smyrk, C Hodgson, D M Wildrick, M L Gope, B M Boman.   

Abstract

We report the first evidence of increased levels of the retinoblastoma (Rb) message in a majority of colorectal cancers when compared with normal mucosa. Southern blot analysis showed an increase in Rb gene copy number in at least 28% of colorectal carcinomas relative to normal mucosa. These results plus previous reports of nonrandom chromosome 13 gains in approximately 50% of colorectal cancers suggest that an increase in Rb gene copy number occurs frequently in these tumors. Possible mechanisms pertaining to overexpression of the Rb gene are discussed in relation to its role as a recessive cancer gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405172     DOI: 10.1093/jnci/82.4.310

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  19 in total

1.  Immunohistochemical study of Cell Cycle Modulators in G(1)-S Transition in Clinical Breast Cancer Tissue.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8.

Authors:  Erick J Morris; Jun-Yuan Ji; Fajun Yang; Luisa Di Stefano; Anabel Herr; Nam-Sung Moon; Eun-Jeong Kwon; Kevin M Haigis; Anders M Näär; Nicholas J Dyson
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

3.  Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer.

Authors:  R Gope; M L Gope
Journal:  Mol Cell Biochem       Date:  1992-03-25       Impact factor: 3.396

4.  Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.

Authors:  P Kanavaros; K Stefanaki; K Valassiadou; J Vlachonikolis; M Mavromanolakis; M Vlychou; S Kakolyris; V Gorgoulis; M Tzardi; V Georgoulias
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

5.  Altered structure and expression of RB1 gene and increased phosphorylation of pRb in human vestibular schwannomas.

Authors:  R Thomas; P D Antony Herold Prabhu; J Mathivanan; D Sivakumar; P N Jayakumar; B Indira Devi; S Satish; K V R Sastry; R Gope
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

6.  Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation.

Authors:  G A Meijer; M A Hermsen; J P Baak; P J van Diest; S G Meuwissen; J A Beliën; J M Hoovers; H Joenje; P J Snijders; J M Walboomers
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

Review 7.  The rb pathway and cancer therapeutics.

Authors:  W Du; J S Searle
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

8.  Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts.

Authors:  M L Gope; M Chun; R Gope
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

9.  Characterization of the DiFi rectal carcinoma cell line derived from a familial adenomatous polyposis patient.

Authors:  M Olive; S Untawale; R J Coffey; M J Siciliano; D M Wildrick; H Fritsche; S Pathak; L M Cherry; M Blick; P Lointier
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

10.  SKP2 Activation by Thyroid Hormone Receptor β2 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells.

Authors:  Xiaoliang L Xu; Zhengke Li; Aihong Liu; Xianqun Fan; Dan-Ning Hu; Dong-Lai Qi; David W Chitty; Renbing Jia; Jianping Qui; Justin Q Wang; Jake Sharaf; Jun Zou; Rebecca Weiss; Hongyan Huang; Walter J Joseph; Lily Ng; Richard Rosen; Binghui Shen; Mark W Reid; Douglas Forrest; David H Abramson; Samuel Singer; David Cobrinik; Suresh C Jhanwar
Journal:  Cancer Res       Date:  2017-09-28       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.